FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Marc Bygdeman

Research Profile

Chemicals & Drugs

Physiology

Concepts & Ideas

Anatomy

Procedures

Administration, Oral

Co-author Network

Publications

TOP 3
Marc Bygdeman; Kristina Gemzell Danielsson
An historical overview of second trimester abortion methods.
S Lalitkumar; Marc Bygdeman; Kristina Gemzell Danielsson
Mid-trimester induced abortion: a review.
Staffan Bergström; Marc Bygdeman; Margareta Rehn; Christina Rogala; Kajsa Sundström; Catharina Zätterström
[Debating the abortion issue is good--but do it as a neglected health problem].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Marc Bygdeman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Marc Bygdeman; Kristina Gemzell Danielsson
An historical overview of second trimester abortion methods.
Reproductive health matters 2008;16(31 Suppl):196-204.
2007: S Lalitkumar; Marc Bygdeman; Kristina Gemzell Danielsson
Mid-trimester induced abortion: a review.
Human reproduction update 2007;13(1):37-52.
2006: Staffan Bergström; Marc Bygdeman; Margareta Rehn; Christina Rogala; Kajsa Sundström; Catharina Zätterström
[Debating the abortion issue is good--but do it as a neglected health problem].
Läkartidningen 2006;103(30-31):2238-9.
2006: Kristina Gemzell Danielsson; Marc Bygdeman; Annette Aronsson
Studies on uterine contractility following mifepristone and various routes of misoprostol.
Contraception 2006;74(1):31-5.
2005: Marc Bygdeman; Anita Ahlenius
[Fetal injury more and more common reason for second trimester abortion].
Läkartidningen 2005;102(8):557-9.
2005: Kristina Gemzell Danielsson; Marc Bygdeman
Effects of progestogens on endometrial maturation in the implantation phase.
Ernst Schering Research Foundation workshop 2005;(52):119-38.
2004: Bela Ganatra; Marc Bygdeman; Bich Thuy Phan; Duc Vinh Nguyen; Manh Loi Vu
From research to reality: the challenges of introducing medical abortion into service delivery in Vietnam.
Reproductive health matters 2004;12(24 Suppl):105-13.
2004: Lena Marions; Sten Z Cekan; Marc Bygdeman; Kristina Gemzell Danielsson
Effect of emergency contraception with levonorgestrel or mifepristone on ovarian function.
Contraception 2004;69(5):373-7.
2004: Annette Aronsson; Marc Bygdeman; Kristina Gemzell Danielsson
Effects of misoprostol on uterine contractility following different routes of administration.
Human reproduction (Oxford, England) 2004;19(1):81-4.
2003: Marc Bygdeman
The possibility of using mifepristone for menstrual induction.
Contraception 2003;68(6):495-8.
2003: Kristina Gemzell Danielsson; Lena Marions; Marc Bygdeman
Effects of mifepristone on endometrial receptivity.
Steroids 2003;68(10-13):1069-75.
2003: Marc Bygdeman
Pharmacokinetics of prostaglandins.
Best practice & research. Clinical obstetrics & gynaecology 2003;17(5):707-16.
2003: Christian Fiala; Peter Safar; Marc Bygdeman; Kristina Gemzell Danielsson
Verifying the effectiveness of medical abortion; ultrasound versus hCG testing.
European journal of obstetrics, gynecology, and reproductive biology 2003;109(2):190-5.
2002: Kristina Gemzell Danielsson; AM van Heusden; S R Killick; H B Croxatto; P Bouchard; S Cameron; Marc Bygdeman
Improving cycle control in progestogen-only contraceptive pill users by intermittent treatment with a new anti-progestogen.
Human reproduction (Oxford, England) 2002;17(10):2588-93.
2002: Marc Bygdeman; Kristina Gemzell Danielsson
Options for early therapeutic abortion: a comparative review.
Drugs 2002;62(17):2459-70.
2000: Kristina Gemzell Danielsson; Marc Bygdeman; Lena Marions
[Knowledge about "morning-after pill" should be spread to all women. Comments on meta-analysis of postcoital contraception].
Läkartidningen 2000;97(50):5892-5.
2000: Marc Bygdeman; Kristina Gemzell Danielsson; Lena Marions; Marja-Liisa Swahn
Pregnancy termination.
Steroids 2000;65(10-11):801-5.
2000: Marc Bygdeman; Kristina Gemzell Danielsson; Lena Marions
Medical termination of early pregnancy: the Swedish experience.
Journal of the American Medical Women's Association (1972) 2000;55(3 Suppl):195-6, 204.
1999: Lena Marions; S Viski; Kristina Gemzell Danielsson; B A Resch; Marja-Liisa Swahn; Marc Bygdeman; L Kovâcs
Contraceptive efficacy of daily administration of 0.5 mg mifepristone.
Human reproduction (Oxford, England) 1999;14(11):2788-90.
1999: P M Stenlund; Gunvor Ekman; AR Aedo; Marc Bygdeman
Induction of labor with mifepristone--a randomized, double-blind study versus placebo.
Acta obstetricia et gynecologica Scandinavica 1999;78(9):793-8.
1999: Marc Bygdeman; Kristina Gemzell Danielsson; Lena Marions; Marja-Liisa Swahn
Contraceptive use of antiprogestin.
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception 1999;4(2):103-7.
1999: Marja-Liisa Swahn; Marc Bygdeman; J K Chen; Kristina Gemzell Danielsson; S Song; Qiwei Yang; P J Yang; M L Qian; W F Chang
Once-a-month treatment with a combination of mifepristone and the prostaglandin analogue misoprostol.
Human reproduction (Oxford, England) 1999;14(2):485-8.
1999: Kristina Gemzell Danielsson; Lena Marions; A Rodriguez; B W Spur; P Y Wong; Marc Bygdeman
Comparison between oral and vaginal administration of misoprostol on uterine contractility.
Obstetrics and gynecology 1999;93(2):275-80.
1998: Lena Marions; Kristina Gemzell Danielsson; Marja-Liisa Swahn; Marc Bygdeman
Contraceptive efficacy of low doses of mifepristone.
Fertility and sterility 1998;70(5):813-6.
1998: Marc Bygdeman
[Misoprostol may cause fetal malformations].
Läkartidningen 1998;95(30-31):3268-9.
1998: Lena Marions; Kristina Gemzell Danielsson; Marc Bygdeman
The effect of antiprogestin on integrin expression in human endometrium: an immunohistochemical study.
Molecular human reproduction 1998;4(5):491-5.
1997: Kristina Gemzell Danielsson; Marja-Liisa Swahn; Marc Bygdeman
The effect of various doses of mifepristone on endometrial leukaemia inhibitory factor expression in the midluteal phase--an immunohistochemical study.
Human reproduction (Oxford, England) 1997;12(6):1293-7.
1997: Marc Bygdeman; Kristina Gemzell Danielsson; Marja-Liisa Swahn
The possible use of antiprogestins for contraception.
Acta obstetricia et gynecologica Scandinavica. Supplement 1997;164():75-7.
1997: Kristina Gemzell Danielsson; Marja-Liisa Swahn; Pär Westlund; E Johannisson; Markku Seppala; Marc Bygdeman
Effect of low daily doses of mifepristone on ovarian function and endometrial development.
Human reproduction (Oxford, England) 1997;12(1):124-31.
1996: Marja-Liisa Swahn; Pär Westlund; E Johannisson; Marc Bygdeman
Effect of post-coital contraceptive methods on the endometrium and the menstrual cycle.
Acta obstetricia et gynecologica Scandinavica 1996;75(8):738-44.
1996: Marc Bygdeman; Marja-Liisa Swahn
Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women.
Maturitas 1996;23(3):259-63.
1996: Marja-Liisa Swahn; Kristina Gemzell Danielsson; Marc Bygdeman
Contraception with anti-progesterone.
Baillière's clinical obstetrics and gynaecology 1996;10(1):43-53.
1996: Kristina Gemzell Danielsson; Pär Westlund; E Johannisson; Marja-Liisa Swahn; Marc Bygdeman; Markku Seppala
Effect of low weekly doses of mifepristone on ovarian function and endometrial development.
Human reproduction (Oxford, England) 1996;11(2):256-64.
1994: Kristina Gemzell Danielsson; P Svalander; Marja-Liisa Swahn; E Johannisson; Marc Bygdeman
Effects of a single post-ovulatory dose of RU486 on endometrial maturation in the implantation phase.
Human reproduction (Oxford, England) 1994;9(12):2398-404.
1994: Marc Bygdeman; Marja-Liisa Swahn; Kristina Gemzell Danielsson; C Gottlieb
The use of progesterone antagonists in combination with prostaglandin for termination of pregnancy.
Human reproduction (Oxford, England) 1994;9 Suppl 1():121-5.
1993: Kristina Gemzell Danielsson; Marja-Liisa Swahn; P Svalander; Marc Bygdeman
Early luteal phase treatment with mifepristone (RU 486) for fertility regulation.
Human reproduction (Oxford, England) 1993;8(6):870-3.
1993: Marc Bygdeman; Marja-Liisa Swahn; Kristina Gemzell Danielsson; P Svalander
Effect of antihormones on endometrial receptors and protein secretion.
European journal of obstetrics, gynecology, and reproductive biology 1993;49(1-2):41-3.
1993: Kristina Gemzell Danielsson; Marja-Liisa Swahn; Marc Bygdeman
Effect of antiprogestin, hCG and a prostaglandin analogue on human uterine contractility.
Contraception 1993;47(3):295-301.
1993: A Rådestad; Marc Bygdeman
Are prostaglandins mediators of mifepristone (RU 486)-induced cervical softening in early pregnancy?
Journal of lipid mediators 1993;6(1-3):503-7.
1993: Marja-Liisa Swahn; Marc Bygdeman; Markku Seppala; E Johannisson; S Cekan
Effect of tamoxifen alone and in combination with RU 486 on the endometrium in the mid-luteal phase.
Human reproduction (Oxford, England) 1993;8(2):193-200.
1993: Marc Bygdeman; Marja-Liisa Swahn; Kristina Gemzell Danielsson; P Svalander
Mode of action of RU 486.
Annals of medicine 1993;25(1):61-4.
1992: Marc Bygdeman
Prostaglandin analogues and their uses.
Baillière's clinical obstetrics and gynaecology 1992;6(4):893-903.
1992: A Rådestad; Marc Bygdeman
Cervical softening with mifepristone (RU 486) after pretreatment with naproxen. A double-blind randomized study.
Contraception 1992;45(3):221-7.
1991: C Gottlieb; K Svanborg; Marc Bygdeman
Adenosine triphosphate (ATP) in human spermatozoa.
Andrologia 1991;23(6):421-5.
1991: Marja-Liisa Swahn; K Gemzell; Marc Bygdeman
Contraception with mifepristone.
Lancet 1991;338(8772):942-3.
1991: P C Svalander; P V Holmes; M Olovsson; Matts Wikland; K Gemzell-Danielsson; Marc Bygdeman
Platelet-derived growth factor is detected in human blastocyst culture medium but not in human follicular fluid--a preliminary report.
Fertility and sterility 1991;56(2):367-9.
1991: E Bendvold; C Gottlieb; Marc Bygdeman; P Eneroth
Depressed semen quality in Swedish men from barren couples: a study over three decades.
Archives of andrology 1991;26(3):189-94.
1991: Marc Bygdeman; K Gemzell; C Gottlieb; Marja-Liisa Swahn
Uterine contractility and interaction between prostaglandins and antiprogestins. Clinical implications.
Annals of the New York Academy of Sciences 1991;626():561-7.
1991: C Gottlieb; Marc Bygdeman
The use of antiprogestin (RU 486) for termination of second trimester pregnancy.
Acta obstetricia et gynecologica Scandinavica 1991;70(3):199-203.
1991: C Gottlieb; Marc Bygdeman; Per Thyberg; B Hellman; Rudolf Rigler
Dynamic laser light scattering compared with video micrography for analysis of sperm velocity and sperm head rotation.
Andrologia 1991;23(1):1-5.
1991: C Gottlieb; V Lundström-Lindstedt; Marja-Liisa Swahn; Marc Bygdeman
Vacuum aspiration for termination of early second trimester pregnancy after treatment with vaginal prostaglandin.
Acta obstetricia et gynecologica Scandinavica 1991;70(1):41-5.
1991: Marc Bygdeman; K Gemzell; Marja-Liisa Swahn
The role of prostaglandins and ovarian hormones in the regulation of human uterine contractility.
Advances in prostaglandin, thromboxane, and leukotriene research 1991;21B():799-806.
1990: K Gemzell; Marja-Liisa Swahn; Marc Bygdeman
Regulation of non-pregnant human uterine contractility. Effect of antihormones.
Contraception 1990;42(3):323-35.
1990: Marja-Liisa Swahn; C Gottlieb; K Green; Marc Bygdeman
Oral administration of RU 486 and 9-methylene PGE2 for termination of early pregnancy.
Contraception 1990;41(5):461-73.
1990: Marja-Liisa Swahn; Marc Bygdeman; S Cekan; S Xing; B Masironi; E Johannisson
The effect of RU 486 administered during the early luteal phase on bleeding pattern, hormonal parameters and endometrium.
Human reproduction (Oxford, England) 1990;5(4):402-8.
1990: A Rådestad; Marc Bygdeman; K Green
Induced cervical ripening with mifepristone (RU 486) and bioconversion of arachidonic acid in human pregnant uterine cervix in the first trimester. A double-blind, randomized, biomechanical and biochemical study.
Contraception 1990;41(3):283-92.
1989: K Svanborg; C Gottlieb; E Bendvold; Marc Bygdeman
Variation in, and inter-relationship between, prostaglandin levels and other semen parameters in normal men.
International journal of andrology 1989;12(6):411-9.
1989: K Bremme; P Eneroth; C Gottlieb; H Kindahl; K Svanborg; B Nilsson; M Olsson; Marc Bygdeman
15-Keto-13,14-dihydroprostaglandin E2- and F2 alpha-metabolite levels in blood from men and women given prostaglandin E2 orally.
Prostaglandins, leukotrienes, and essential fatty acids 1989;37(3):169-76.
1989: Marja-Liisa Swahn; Marc Bygdeman; S A Matlin; Z Y Wu
The effect of tamoxifen on the function and lifespan of the corpus luteum and on subsequent ovarian function.
Acta endocrinologica 1989;121(3):417-25.
1989: Marc Bygdeman; Paul F. A. Van Look
The use of prostaglandins and antiprogestins for pregnancy termination.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 1989;29(1):5-12.
1989: E Johannisson; M Oberholzer; Marja-Liisa Swahn; Marc Bygdeman
Vascular changes in the human endometrium following the administration of the progesterone antagonist RU 486.
Contraception 1989;39(1):103-17.
1989: Marja-Liisa Swahn; Marc Bygdeman
Termination of early pregnancy with RU 486 (mifepristone) in combination with a prostaglandin analogue (sulprostone).
Acta obstetricia et gynecologica Scandinavica 1989;68(4):293-300.
1989: Marja-Liisa Swahn; G Ugocsai; Marc Bygdeman; L Kovacs; E M Belsey; Paul F A Van Look
Effect of oral prostaglandin E2 on uterine contractility and outcome of treatment in women receiving RU 486 (mifepristone) for termination of early pregnancy.
Human reproduction (Oxford, England) 1989;4(1):21-8.
1989: Marc Bygdeman; Marja-Liisa Swahn
Prostaglandins and antiprogestins.
Acta obstetricia et gynecologica Scandinavica. Supplement 1989;149():13-8.
1989: Gabriel Fried; Eva Ostlund; C Ullberg; Marc Bygdeman
Somatic complications and contraceptive techniques following legal abortion.
Acta obstetricia et gynecologica Scandinavica 1989;68(6):515-21.
1988: C Gottlieb; K Bremme; K Svanborg; P Eneroth; Marc Bygdeman
The effects of oral administration of prostaglandin E2 on the human ejaculate.
Fertility and sterility 1988;50(5):789-94.
1988: Marja-Liisa Swahn; E Johannisson; VITTORIO DANIORE; B de la Torre; Marc Bygdeman
The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
Human reproduction (Oxford, England) 1988;3(7):915-21.
1988: M Hedman; C Gottlieb; K Svanborg; Marc Bygdeman; B de la Torre
Endocrine, seminal and peripheral effects of depot medroxyprogesterone acetate and testosterone enanthate in men.
International journal of andrology 1988;11(4):265-76.
1988: Marja-Liisa Swahn; Marc Bygdeman
The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin.
British journal of obstetrics and gynaecology 1988;95(2):126-34.
1988: C Gottlieb; K Svanborg; P Eneroth; Marc Bygdeman
Effect of prostaglandins on human sperm function in vitro and seminal adenosine triphosphate content.
Fertility and sterility 1988;49(2):322-7.
1988: C Gottlieb; Marc Bygdeman
Prostanoids in sperm function.
Prostaglandins, leukotrienes, and essential fatty acids 1988;34(3):205-14.
1987: C Gottlieb; K Svanborg; P Eneroth; Marc Bygdeman
Adenosine triphosphate in human semen: a study on conditions for a bioluminescence assay.
Fertility and sterility 1987;47(6):992-9.
1987: E Bendvold; C Gottlieb; K Svanborg; Marc Bygdeman; P Eneroth
Concentration of prostaglandins in seminal fluid of fertile men.
International journal of andrology 1987;10(2):463-9.
1987: Marc Bygdeman; C Gottlieb; K Svanborg; Marja-Liisa Swahn
Role of prostaglandins in human reproduction: recent advances.
Advances in prostaglandin, thromboxane, and leukotriene research 1987;17B():1112-6.
1986: Marja-Liisa Swahn; G Wang; A R Aedo; S Z Cekan; Marc Bygdeman
Plasma levels of antiprogestin RU 486 following oral administration to non-pregnant and early pregnant women.
Contraception 1986;34(5):469-81.
1986: E Bendvold; C Gottlieb; K Svanborg; H Gilljam; B Strandvik; Marc Bygdeman; P Eneroth
Absence of prostaglandins in semen of men with cystic fibrosis is an indication of the contribution of the seminal vesicles.
Journal of reproduction and fertility 1986;78(1):311-4.
1985: E Bendvold; C Gottlieb; K Svanborg; Marc Bygdeman; P Eneroth; Q H Cai
The effect of naproxen on the concentration of prostaglandins in human seminal fluid.
Fertility and sterility 1985;43(6):922-6.
1985: E Bendvold; K Svanborg; Marc Bygdeman; S Norén
On the origin of prostaglandins in human seminal fluid.
International journal of andrology 1985;8(1):37-43.
1985: Marc Bygdeman; E Bendvold; C Gottlieb; K Svanborg; P Eneroth
Prostaglandins and male fertility.
Advances in prostaglandin, thromboxane, and leukotriene research 1985;15():609-11.
1984: L Kovacs; M Sas; B A Resch; G Ugocsai; Marja-Liisa Swahn; Marc Bygdeman; P J Rowe
Termination of very early pregnancy by RU 486--an antiprogestational compound.
Contraception 1984;29(5):399-410.
1984: E Bendvold; K Svanborg; P Eneroth; C Gottlieb; Marc Bygdeman
The natural variations in prostaglandin concentration in human seminal fluid and its relation to sperm quality.
Fertility and sterility 1984;41(5):743-7.
1983: K Svanborg; E Bendvold; Marc Bygdeman; P Eneroth
Relationship between prostaglandins in human seminal fluid and fertility.
Advances in prostaglandin, thromboxane, and leukotriene research 1983;12():455-9.
1982: K Svanborg; Marc Bygdeman; P Eneroth; E Bendvold
Quantification of prostaglandins in human seminal fluid.
Prostaglandins 1982;24(3):363-75.